dc.contributor.author | Grønseth, Stine | |
dc.contributor.author | Rogne, Tormod | |
dc.contributor.author | Hannula, Raisa | |
dc.contributor.author | Åsvold, Bjørn Olav | |
dc.contributor.author | Afset, Jan Egil | |
dc.contributor.author | Damås, Jan Kristian | |
dc.date.accessioned | 2023-03-02T13:17:32Z | |
dc.date.available | 2023-03-02T13:17:32Z | |
dc.date.created | 2021-12-14T12:20:18Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | BMC Infectious Diseases. 2021, 21 (1), . | en_US |
dc.identifier.issn | 1471-2334 | |
dc.identifier.uri | https://hdl.handle.net/11250/3055420 | |
dc.language.iso | eng | en_US |
dc.rights | Navngivelse 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/deed.no | * |
dc.title | Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway | en_US |
dc.title.alternative | Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway | en_US |
dc.type | Journal article | en_US |
dc.type | Peer reviewed | en_US |
dc.description.version | publishedVersion | en_US |
dc.source.pagenumber | 0 | en_US |
dc.source.volume | 21 | en_US |
dc.source.journal | BMC Infectious Diseases | en_US |
dc.source.issue | 1 | en_US |
dc.identifier.doi | 10.1186/s12879-021-06144-1 | |
dc.identifier.cristin | 1968326 | |
dc.relation.project | Norges forskningsråd: 223255 | en_US |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |